| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.16B | +4.5% |
| Cost of Revenue | $516.3M | +2.8% |
| Gross Profit | $639.2M | +6.0% |
| R&D Expense | $160.6M | +4.8% |
| SG&A Expense | $142.7M | -24.9% |
| Operating Income | -$270.5M | -705.1% |
| Interest Expense | $55.6M | +39.4% |
| Pre-tax Income | -$311.6M | -1866.0% |
| Income Tax | -$28.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.6M | +116.4% |
| Accounts Receivable | $83.5M | -18.0% |
| Current Assets | $976.3M | +5.0% |
| Total Assets | $2.50B | -14.3% |
| Current Liabilities | $1.25B | +4.6% |
| Long-term Debt | $1.08B | +38.0% |
| Total Liabilities | $2.35B | +11.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $296.0M | +48.3% |
| Capital Expenditures | $7.4M | +58.9% |
| Investing Cash Flow | -$73.4M | -14.0% |
| Financing Cash Flow | -$139.4M | +2.5% |
| Free Cash Flow | $288.5M | +48.0% |
| -279.6% |
| Net Income | -$283.2M | — |
| EPS (Basic) | -$5.60 | — |
| EPS (Diluted) | -$5.60 | — |
| Stockholders' Equity |
| $142.0M |
| -82.4% |